首页 | 本学科首页   官方微博 | 高级检索  
检索        

复方联苯苄唑液治疗浅部真菌病双盲对照研究
引用本文:罗庆录,吴绍熙,王爱平,廖万清,席丽艳,金学洙,祖尔立.复方联苯苄唑液治疗浅部真菌病双盲对照研究[J].中华皮肤科杂志,2003,36(8):433-435.
作者姓名:罗庆录  吴绍熙  王爱平  廖万清  席丽艳  金学洙  祖尔立
作者单位:1. 吉林省吉林市北华大学附属医院皮肤科 132011;2. 中国医学科学院、中国协和医科大学皮肤病研究所;3. 北京大学第一医院;4. 第二军医大学长征医院;5. 吉林大学第二医院;6. 吉林市中心医院
摘    要:目的 为了研究复方联苯苄唑液对浅部真菌病的疗效。方法 采用双盲对照的方法。试验组为复方联苯苄唑液,对照组为克霉唑癣药水。均每日涂患部1次,疗程体股癣为2周,手足癣为4周,停药后随访2周,主要观察红斑、丘疹、水疱、鳞屑、角化和瘙痒,评价治疗后每周的皮损情况。每例患者于疗前、疗中及疗后,停药后2周作真菌学检查。结果 观察434例患者,复方联苯苄唑液临床治愈率体股癣为82.25%,手足癣为68.75%,总有效率体股癣为95.85%,手足癣为92.5%;对照组治疗体股癣痊愈率为58.6%,手足癣为44.7%,有效率体股癣为83.0%,手足癣为87.2%。临床350株常见致病菌,复方联苯苄唑液的MIC为1.6~12.5mg/L,克霉唑药水的MIC为3.125~25mg/L。结论 复方联苯苄唑液是高效、广谱的抗真菌药物。本药能溶解、松解角质,渗透性好,可长期应用。

关 键 词:  克霉唑  联苯苄唑  投药  皮肤  
收稿时间:2002-08-16
修稿时间:2002年8月16日

Treatment of Superficial Mycosis with Compound Bifonazole Solution: A Double-blind Controlled Clinical Trial
LUO Qing-lu ,WU Shao-xi,WANG Ai-ping,LIAO Wan-qing,XI Li-yan,JIN Xue-zhu,ZU Er-li.Treatment of Superficial Mycosis with Compound Bifonazole Solution: A Double-blind Controlled Clinical Trial[J].Chinese Journal of Dermatology,2003,36(8):433-435.
Authors:LUO Qing-lu  WU Shao-xi  WANG Ai-ping  LIAO Wan-qing  XI Li-yan  JIN Xue-zhu  ZU Er-li
Institution:Affiliated Hospital of Medical College of Beihua University, Jilin 132011, China
Abstract:Objective To investigate the effects of compound bifonazole solution for the treatment of superficial mycosis.Methods The study groups were treated with compound bifonazole solution and the control group with clotrimazole solution in a double-blind controlled clinical trial.The solutions were applied to skin lesions once a day.The course of treatment was two weeks for tinea corporis and tinea cruris and four weeks for tinea manus and tinea pedis.The patients were followed up weekly for two weeks after cessation of treatment and evaluated with regard to erythema,papule,blister,scale,keratinization and pruritus.Mycologic examinations were performed before,during and right after treatment and two weeks after treatment.Results A total of434patients participated into the study.The clinical cure rates of study group were82.25%in tinea corporis and tinea cruris,and68.75%tinea manus and tinea pedis,with a total response rates of95.85%and92.5%in tinea corporis and tinea cruris,and92.5%in tinea manus and tinea pedis,respectively.The clinical cure rates of control group were58.6%in tinea corporis and tinea cruris,and44.7%in tinea manus and tinea pedis,with a total response rates of83.0%and87.2%in tinea corporis and tinea cruris,and in tinea manus and tinea pedis,respectively.The MICs to350clinical isolates of pathogenic fungi were1.6~2.5mg/L for compound bifonazole solution,and3.125~25mg/L for clotrimazole solution.Conclusions Compound bifonazole solution is a high-effective,broad-spectrum anti-fungal agent.It is keratolytic,well permeable and safe for relatively long term application.
Keywords:Tinea  Clotrimazole  Bifonazole  Administration  cutaneous
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中华皮肤科杂志》浏览原始摘要信息
点击此处可从《中华皮肤科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号